Peter A. McCullough, MD, MPH™ – Telegram
Peter A. McCullough, MD, MPH
27.1K subscribers
747 photos
611 videos
14 files
4.99K links
Physician-scientist, author, commentator, Chief Scientific Officer, The Wellness Company, President, McCullough Foundation, www.petermcculloughmd.com
Download Telegram
Dr. McCullough did a video interview with Joseph Arthur formerly of REM. He clearly understands COVID-19 the lack of compassion and denial of treatment to those in need. The spirit is strong in him and he makes us all feel stronger in the kingdom. Truth and justice will prevail. https://www.youtube.com/watch?v=uNF2cbW37mo
Useful talking points for your messaging: 1. In 1990, the Vaccine Adverse Event Reporting Systems (“VAERS”) was established as a national early warning system to detect possible safety problems in U.S. licensed vaccines. VAERS is a passive reporting system, meaning it relies on individuals to voluntarily send in reports of their experiences to CDC and FDA. VAERS is useful in detecting unusual or unexpected patterns of adverse event reporting that might indicate a possible safety problem with a vaccine.

2. The total safety reports in VAERS all vaccines per year up to 2019 was 16,320. The total safety reports in VAERS for COVID Vaccines alone through Jun 11, 2021 is 358,379.

3. Based on VAERS as of June 11, 2021, there were 5,993 COVID-19 vaccine deaths reported and over 20,737 hospitalizations reported. By comparison, from July 1, 1997, until December 31, 2013, VAERS received 666 adult death reports for all vaccines combined.

4. Thus the COVID-19 vaccines are not safe for general use and cannot be deployed indiscriminately.

5. The safety profile is unknown and there is a reasonable expectation for harm for the following groups: COVID-19 recovered, suspected COVID-19 recovered, women of childbearing potential, children, persons with one or more chronic diseases.
Don't fear the Delta. Here is why https://youtu.be/TtOu7jx3snQ
Covid-19 vaccines: Citizen Petition urges FDA against premature full approval. Many open, unanswered questions about benefits and harms must be answered https://bit.ly/3cieneX before the FDA considers granting a full approval. FDA will respond here https://bit.ly/3vMheEK